PHARMACEUTICAL PRODUCT DEVELOPMENT INC Net Change in Cash
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Net Change in Cash of -$62.83 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC cash and cash equivalents, period increase (decrease) for the quarter ending 2011-09-30 was $45.88M, a 620.51% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC cash and cash equivalents, period increase (decrease) for the quarter ending 2011-06-30 was $21.09M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC cash and cash equivalents, period increase (decrease) for the quarter ending 2011-03-31 was -$129.80M, a 281.10% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC cash and cash equivalents, period increase (decrease) for the quarter ending 2010-12-31 was $39.13M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC cash and cash equivalents, period increase (decrease) for fiscal 2010 was $70.67M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC cash and cash equivalents, period increase (decrease) for fiscal 2009 was -$82.85M, a 125.86% decline from fiscal 2008.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC cash and cash equivalents, period increase (decrease) for fiscal 2008 was $320.33M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2011-09-30 | $45.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $66.97M derived: sum of 2 quarters · filed 2011-11-02 | -$62.83M 10-Q · filed 2011-11-02 | -$23.70M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-06-30 | $21.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | -$108.71M 10-Q · filed 2011-08-04 | -$69.58M derived: sum of 3 quarters · filed 2011-08-04 | -$63.21M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-03-31 | -$129.80M 10-Q · filed 2011-05-03 | -$90.66M derived: sum of 2 quarters · filed 2011-05-03 | -$84.30M derived: sum of 3 quarters · filed 2011-11-02 | -$130.79M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-12-31 | $39.13M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $45.50M derived: sum of 2 quarters · filed 2011-11-02 | -$998.00K derived: sum of 3 quarters · filed 2011-11-02 | $70.67M 10-K · filed 2011-02-25 |
| 2010-09-30 | $6.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$40.13M derived: sum of 2 quarters · filed 2011-11-02 | $31.54M 10-Q · filed 2011-11-02 | $2.85M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-06-30 | -$46.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $25.17M 10-Q · filed 2011-08-04 | -$3.52M derived: sum of 3 quarters · filed 2011-08-04 | -$125.77M derived: sum of 4 quarters · filed 2011-08-04 |
| 2010-03-31 | $71.67M 10-Q · filed 2011-05-03 | $42.98M derived: sum of 2 quarters · filed 2011-05-03 | -$79.27M derived: sum of 3 quarters · filed 2011-05-03 | |
| 2009-12-31 | -$28.69M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | -$150.94M derived: sum of 2 quarters · filed 2011-02-25 | -$82.85M 10-K · filed 2011-02-25 | |
| 2009-09-30 | -$122.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | -$54.16M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $68.08M 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | $320.33M 10-K · filed 2011-02-25 |